Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
»
DOJ Sues Regeneron for Allegedly Inflating Medicare Pricing for Eye Drug Eylea
BioSpace
Thu, 04/11/24 - 11:27 am
DOJ
Regeneron
Medicare
Eylea
drug pricing
False Claims Act
Number of ongoing US drug shortages reaches new high, pharmacist group says
Fierce Pharma
Thu, 04/11/24 - 11:13 am
drug shortages
pharmacists
For Chinese biotechs, the out-licensing business is scorching hot. Could geopolitics rain on their parade?
Fierce Biotech
Thu, 04/11/24 - 11:09 am
China
biotech
out-licensing
geopolitics
Top five biopharma companies hiring in San Diego
BioSpace
Thu, 04/11/24 - 10:55 am
San Diego
biotech
hirings
Avidity Biosciences
Element Biosciences
AnaptysBio
Fate Therapeutics
Takeda
FDA puts breakthrough tag on Roche, Lilly Alzheimer’s test
Pharmaphorum
Thu, 04/11/24 - 10:52 am
diagnostics
Roche
Eli Lilly
Alzheimer's disease
FDA
breakthrough designation
Reports: Applying gen AI to marketing can help life-sci firms unlock billions
Medical Marketing and Media
Thu, 04/11/24 - 10:46 am
pharma marketing
artificial intelligence
generative AI
Vertex to buy kidney disease drugmaker Alpine for $4.9B
BioPharma Dive
Wed, 04/10/24 - 06:05 pm
Vertex Pharmaceuticals
M&A
Alpine Immune Sciences
IgA nephropathy
J&J, Rallybio partner on drug development for rare fetal condition
BioPharma Dive
Wed, 04/10/24 - 06:01 pm
JNJ
Rallybio
FNAIT
drug development
Alkermes reports data from Phase Ib narcolepsy treatment trial
Clinical Trials Arena
Wed, 04/10/24 - 06:00 pm
Alkermes
clinical trials
narcolepsy
ALKS 2680
Leading AstraZeneca investor defends CEO pay ahead of shareholder vote
Fierce Pharma
Wed, 04/10/24 - 05:47 pm
AstraZeneca
Pascal Soriot
Pharma CEOs
executive compensation
AACR: Study Suggests Accelerated Approval Doesn’t Always Lead to Clinical Benefit
BioSpace
Wed, 04/10/24 - 05:44 pm
AACR
oncology
FDA
accelerated approvals
Novartis pauses enrollment in some Kisqali trials to fix manufacturing
BioPharma Dive
Wed, 04/10/24 - 05:28 pm
Novartis
Kisqali
drug manufacturing
breast cancer
clinical trials
April 10 2024 - The IRA is already curtailing small molecule drug development. Here’s how to reverse that.
Wed, 04/10/24 - 11:31 am
The IRA Is Already Curtailing Small Molecule Drug Development. Here’s How to Reverse That.
BioSpace
Wed, 04/10/24 - 11:27 am
small molecule drugs
drug development
Inflation Reduction Act
innovation
7 Billion-Dollar Oncology M&As from Q1
BioSpace
Wed, 04/10/24 - 11:24 am
oncology
M&A
AbbVie
Immunogen
Bristol Myers Squibb
Mirati Therapeutics
RayzeBio
Novartis
MorphoSys
AstraZeneca
Fusion Pharmaceuticals
JNJ
Ambrx
Gracell
AACR: Merck, Kelun’s Anti-TROP2 ADC Shows Early Promise in Gastric Cancer
BioSpace
Wed, 04/10/24 - 09:59 am
Merck
Kelun-Biotech
SKB264
gastric cancer
antibody-drug conjugate
clinical trials
AACR
New Cardiovascular Company Emerges from Stealth Mode
Medical Devices and Diagnostics Industry
Wed, 04/10/24 - 09:57 am
Reprieve Cardiovascular
funding
acute decompensated heart failure
Bristol Myers-backed TORL secures $158M to march army of ADCs through clinic
Fierce Biotech
Wed, 04/10/24 - 09:52 am
Bristol Myers Squibb
TORL BioTherapeutics
antibody-drug conjugate
funding
Invenra, Astellas sign bispecific antibody discovery agreement
Pharmaceutical Business Review
Wed, 04/10/24 - 09:50 am
Astellas
Invenra
B-Body
bispecific antibodies
R&D
GLP-1s Like Novo Nordisk’s Ozempic Do Not Increase Thyroid Cancer Risk: Study
BioSpace
Wed, 04/10/24 - 09:48 am
Novo Nordisk
Ozempic
Victoza
GLP-1 agonist
thyroid cancer
Pages
« first
‹ previous
…
8
9
10
11
12
13
14
15
16
…
next ›
last »